Загрузка...
A novel combinatorial cancer immunotherapy: poly-IC and blockade of the PD-1/PD-L1 pathway
A non-antigen specific immunotherapy consisting of repeated co-administration of poly-IC and blocking antibodies targeting the programmed cell death-1 (PD-1) pathway dramatically inhibits tumor development in several mouse models of cancer. Tumor-reactive CD8(+) T cells mediate the antitumor effects...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Landes Bioscience
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4063146/ https://ncbi.nlm.nih.gov/pubmed/25050210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.28440 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|